Citigroup’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $305M | Buy |
682,807
+142,877
| +26% | +$66.6M | 0.13% | 153 |
|
|
2025
Q4 | $245M | Sell |
539,930
-65
| -0% | -$28K | 0.11% | 166 |
|
|
2025
Q3 | $211M | Sell |
539,995
-59,084
| -10% | -$24.7M | 0.09% | 208 |
|
|
2025
Q2 | $267M | Sell |
599,079
-28,636
| -5% | -$13.2M | 0.13% | 150 |
|
|
2025
Q1 | $304M | Buy |
627,715
+165,647
| +36% | +$77.2M | 0.16% | 113 |
|
|
2024
Q4 | $186M | Sell |
462,068
-126,352
| -21% | -$58.6M | 0.11% | 169 |
|
|
2024
Q3 | $274M | Buy |
588,420
+108,813
| +23% | +$52.3M | 0.16% | 117 |
|
|
2024
Q2 | $225M | Buy |
479,607
+79,839
| +20% | +$34.7M | 0.14% | 134 |
|
|
2024
Q1 | $167M | Sell |
399,768
-54,824
| -12% | -$23.2M | 0.11% | 174 |
|
|
2023
Q4 | $185M | Buy |
454,592
+8,995
| +2% | +$3.32M | 0.13% | 138 |
|
|
2023
Q3 | $155M | Sell |
445,597
-17,399
| -4% | -$6.09M | 0.12% | 146 |
|
|
2023
Q2 | $163M | Buy |
462,996
+38,119
| +9% | +$12.8M | 0.11% | 142 |
|
|
2023
Q1 | $134M | Sell |
424,877
-59,620
| -12% | -$17.9M | 0.09% | 170 |
|
|
2022
Q4 | $140M | Buy |
484,497
+1,256
| +0.3% | +$383K | 0.11% | 167 |
|
|
2022
Q3 | $140M | Buy |
483,241
+365
| +0.1% | +$105K | 0.1% | 157 |
|
|
2022
Q2 | $136M | Sell |
482,876
-35,160
| -7% | -$9.41M | 0.1% | 170 |
|
|
2022
Q1 | $135M | Sell |
518,036
-141,335
| -21% | -$33.5M | 0.08% | 213 |
|
|
2021
Q4 | $145M | Buy |
659,371
+79,762
| +14% | +$15.5M | 0.08% | 229 |
|
|
2021
Q3 | $105M | Sell |
579,609
-120,472
| -17% | -$23.5M | 0.06% | 278 |
|
|
2021
Q2 | $141M | Buy |
700,081
+61,546
| +10% | +$12.9M | 0.09% | 210 |
|
|
2021
Q1 | $137M | Buy |
638,535
+132,354
| +26% | +$29.1M | 0.09% | 214 |
|
|
2020
Q4 | $120M | Buy |
506,181
+172,180
| +52% | +$39.5M | 0.07% | 250 |
|
|
2020
Q3 | $90.9M | Sell |
334,001
-30,379
| -8% | -$8.38M | 0.06% | 264 |
|
|
2020
Q2 | $106M | Buy |
364,380
+124,655
| +52% | +$33.8M | 0.08% | 204 |
|
|
2020
Q1 | $57M | Buy |
239,725
+6,115
| +3% | +$1.4M | 0.05% | 319 |
|
|
2019
Q4 | $51.1M | Sell |
233,610
-86,088
| -27% | -$17.4M | 0.04% | 497 |
|
|
2019
Q3 | $54.2M | Sell |
319,698
-54,623
| -15% | -$9.66M | 0.04% | 413 |
|
|
2019
Q2 | $68.6M | Buy |
374,321
+119,212
| +47% | +$20.8M | 0.06% | 329 |
|
|
2019
Q1 | $46.9M | Buy |
255,109
+39,637
| +18% | +$7.32M | 0.05% | 416 |
|
|
2018
Q4 | $35.7M | Buy |
215,472
+41,995
| +24% | +$7.28M | 0.04% | 530 |
|
|
2018
Q3 | $33.4M | Buy |
173,477
+73,630
| +74% | +$13.1M | 0.03% | 556 |
|
|
2018
Q2 | $17M | Sell |
99,847
-85,780
| -46% | -$13.3M | 0.02% | 908 |
|
|
2018
Q1 | $30.3M | Buy |
185,627
+27,114
| +17% | +$4.43M | 0.02% | 579 |
|
|
2017
Q4 | $23.8M | Buy |
158,513
+20,162
| +15% | +$2.99M | 0.02% | 751 |
|
|
2017
Q3 | $21M | Sell |
138,351
-46,855
| -25% | -$7.05M | 0.02% | 767 |
|
|
2017
Q2 | $23.9M | Buy |
185,206
+4,563
| +3% | +$549K | 0.02% | 673 |
|
|
2017
Q1 | $19.8M | Sell |
180,643
-34,053
| -16% | -$3M | 0.02% | 745 |
|
|
2016
Q4 | $15.8M | Buy |
214,696
+146,012
| +213% | +$11.9M | 0.01% | 903 |
|
|
2016
Q3 | $5.99M | Sell |
68,684
-10,129
| -13% | -$957K | 0.01% | 1507 |
|
|
2016
Q2 | $6.78M | Sell |
78,813
-24,301
| -24% | -$2.1M | 0.01% | 1303 |
|
|
2016
Q1 | $8.2M | Buy |
103,114
+29,352
| +40% | +$2.65M | 0.01% | 1149 |
|
|
2015
Q4 | $9.28M | Sell |
73,762
-58,233
| -44% | -$7.03M | 0.01% | 1203 |
|
|
2015
Q3 | $13.7M | Sell |
131,995
-7,988
| -6% | -$1.03M | 0.01% | 923 |
|
|
2015
Q2 | $17.3M | Sell |
139,983
-39,044
| -22% | -$4.92M | 0.02% | 866 |
|
|
2015
Q1 | $21.1M | Sell |
179,027
-2,627
| -1% | -$315K | 0.02% | 740 |
|
|
2014
Q4 | $21.6M | Buy |
181,654
+19,091
| +12% | +$2.15M | 0.02% | 766 |
|
|
2014
Q3 | $18.3M | Sell |
162,563
-220,559
| -58% | -$21M | 0.02% | 860 |
|
|
2014
Q2 | $36.3M | Buy |
383,122
+200,774
| +110% | +$14.1M | 0.03% | 482 |
|
|
2014
Q1 | $12.9M | Sell |
182,348
-15,974
| -8% | -$1.27M | 0.01% | 984 |
|
|
2013
Q4 | $14.7M | Buy |
198,322
+19,625
| +11% | +$1.37M | 0.01% | 952 |
|
|
2013
Q3 | $13.5M | Buy |
178,697
+63,709
| +55% | +$5.07M | 0.01% | 947 |
|
|
2013
Q2 | $9.18M | Buy |
+114,988
| New | +$8.47M | 0.01% | 1142 |
|
Other funds holding VRTX
VCM
VPM
Citigroup's VRTX Position: Q1 2026 in Review
Citigroup increased its Vertex Pharmaceuticals (VRTX) stake by 26% in Q1 2026, buying an estimated $66.6M and bringing the position to 682,807 shares worth $305M. The position accounts for 0.13% of the portfolio, ranked #153.
Citigroup first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Citigroup held 682,807 shares of Vertex Pharmaceuticals worth $305M as of Q1 2026.
- Citigroup bought 142,877 Vertex Pharmaceuticals shares in Q1 2026, an estimated $66.6M.
- Vertex Pharmaceuticals made up 0.13% of Citigroup's portfolio in Q1 2026, its #153 holding.
- Citigroup first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.